The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so that patients can live better lives. NCCN offers a number of programs and resources to give clinicians access to tools and knowledge that can help guide decision-making in the management of cancer, including the flagship product, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The NCCN Guidelines provide evidence-based, consensus-driven guidance for cancer management to ensure that all patients receive preventive, diagnostic, therapeutic, and supportive services that are most likely to lead to optimal outcomes. They are intended to assist all individuals who impact decision-making in cancer care including physicians, nurses, pharmacists, payers, patients and their families, and many others. The development of the NCCN Guidelines is an ongoing and iterative process based on a critical review of the best available evidence and the consensus recommendations made by a multidisciplinary panel of oncology experts. The NCCN Guidelines are the most detailed and frequently-updated clinical practice guidelines available in any area of medicine and are the recognized standard for cancer care throughout the world. NCCN Guidelines are used by clinicians, payers and other health care decision-makers around the world to ensure delivery of high-quality, accessible, patient-centered care aimed at optimizing patient outcomes. BACKGROUND A recent article provided compelling evidence for a cardioprotective effect of afternoon compared with morning surgery in patients undergoing aortic valve replacement. The present study sought to investigate any daytime-dependent effect on perioperative myocardial injury and/or clinical outcomes in a large cohort of patients undergoing elective cardiac surgery METHODS We identified all patients, who underwent non-emergent aortic valve replacement and/or on-pump coronary artery bypass grafting at our department between 1999 and 2018. Propensity-score matching was used to create adjusted cohorts for morning and afternoon surgery. The primary endpoint was a composite of 30-day mortality and in-hospital acute myocardial infarction (major adverse cardiac events). Secondary endpoints were new-onset in-hospital atrial fibrillation, peak creatine-kinase MB levels and up to 19 years of follow-up for all-cause mortality. RESULTS We identified 7,148 patients who underwent either aortic valve replacement with or without coronary artery bypass grafting (n=2,806) or isolated coronary artery bypass grafting (n=4,342). Propensity-score matching resulted in comparable cohorts of morning and afternoon surgery. The morning and afternoon surgery cohorts had no differences in the rates of major adverse cardiac events following both procedures. https://www.selleckchem.com/products/acetylcysteine.html Similarly, no daytime-dependent variation in the rate of new-onset in-hospital atrial fibrillation, long-term all-cause mortality or peak creatine-kinase MB levels could be identified. CONCLUSIONS In this large cohort study of Danish patients, who underwent either aortic valve replacement and/or coronary artery bypass grafting, we identified no clinically relevant biorhythm for myocardial ischemia-reperfusion tolerance. As coronavirus disease 2019 (COVID-19) infection spreads globally, the demand for chest imaging will inevitably rise with an accompanying increase in risk of disease transmission to frontline radiology staff. Radiology departments should implement strict infection control measures and robust operational plans to minimize disease transmission and mitigate potential impact of possible staff infection. In this article, the authors share several operational guidelines and strategies implemented in our practice to reduce spread of COVID-19 and maintain clinical and educational needs of a teaching hospital. Glucuronidation is one of the major metabolic pathways for flavonoids. However, quantification of flavonoid glucuronides in biological samples, especially in the bile, is sometimes challenging due to signal suppression by bile acids. The purpose of this study is to establish a robust LC-MS/MS method for directly measuring flavonoid glucuronides in bile and blood. Wogonoside (wongonin-glucuronide), baicalin (baicalein-glucuronide) and apigenin-7-O-glucuronide were used as the model compounds and taurocholic acid (T-CA) were used as the model bile acid to establish the method. Bile samples were processed using solid phase extraction (SPE) and blood samples were prepared using protein precipitation method. The analytes were separated on a Resteck HPLC (50 mm × 2.1 mm ID, 1.7 μm) column using acetonitrile and 2.5mM ammonium acetate (pH=7.4) in water as the mobile phases. The mass analysis was performed in an AB Sciex 5500 Qtrap mass spectrometer via multiple reaction monitoring (MRM) in the positive mode. The results showed that the linear range of the above three analytes were 10 nM to 5000 nM in the bile and 1.56 nM to 4000 nM in the blood, respectively. The recoveries of three glucuronides were >85% and the matrix effects were 90% of these bile acids were removed by the selected SPE procedure to facilitate glucuronide analysis. The validated method was successfully applied to a portal vein infusion study using rats to quantify baicalin, wogonoside, and apigenin-glucuronide in bile and blood samples. The orientation dependence of the Raman spectral features of individual protein/biomolecules is studied using surface-enhanced Raman spectroscopy (SERS). Large variation in spectral features mainly in term of peak intensity is observed from small proteins/peptides. We aim to address the question of whether the spectral features of SERS are uniquely determined by the type of protein/molecules or are influenced prominently by factors more than the identity of the molecules such as orientation of molecules relative to the substrate surface. The standard deviation in the intensity of individual Raman peaks diminishes for protein size larger than 13 amino acids. Secondary structure of protein (such as protein-protein interaction) remains unchanged regardless of protein orientation. Numerical simulation studies corroborate the experimental observation in that the SERS spectral features of biomedically relevant protein (of larger than 13 amino acids in size, which represent all human protein types) are not affected by the orientation of amino acids randomly dispersed on SERS-active surfaces.